TAKAYASU ARTERITIS
Clinical trials for TAKAYASU ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new TAKAYASU ARTERITIS trials appear
Sign up with your email to follow new studies for TAKAYASU ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood vessel disease: drug targets inflammation at its source
Disease control Not yet recruitingThis study tests a drug called secukinumab in 52 people with active, severe Takayasu arteritis, a rare disease that causes inflammation and narrowing of major blood vessels. The goal is to see if secukinumab can help patients stop taking steroids and achieve remission. Participan…
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
Could a lung drug fix blood vessel damage in rare artery disease?
Disease control Not yet recruitingThis study tests whether adding pirfenidone, a drug used for lung and liver scarring, to standard treatment can improve blood vessel damage in people with Takayasu arteritis. About 92 adults aged 18-60 will receive either pirfenidone or a placebo for 6 months. The goal is to see …
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC
-
New scanner could sharpen view of hidden artery inflammation
Diagnosis Not yet recruitingThis study tests a new, more sensitive PET/CT scanner (LAFOV) to see if it can detect blood vessel inflammation more clearly in people with large vessel vasculitis. Researchers will compare scans from 18 patients and healthy volunteers to develop a standard imaging protocol. The …
Matched conditions: TAKAYASU ARTERITIS
Phase: NA • Sponsor: Imperial College London • Aim: Diagnosis
Last updated Jun 08, 2026 13:07 UTC